ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,561, issued on May 20, was assigned to BioNTech US Inc. (Cambridge, Mass.).
"Protein antigens and uses thereof" was invented by Michael Steven Rooney (Boston).
According to the abstract* released by the U.S. Patent & Trademark Office: "The field of the present invention relates to immunotherapeutic peptides, peptide binding agents, and their use, for example, in the immunotherapy of cancer."
The patent was filed on April 3, 2018, under Application No. 16/500,707.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=1...